Results 191 to 200 of about 29,283 (270)

Blood‐Based Circulating Tumor DNA Assays for Early Colorectal Cancer Detection: A Systematic Review of Performance in Asymptomatic Screening Populations

International Journal of Cancer, Volume 159, Issue 4, Page 1028-1041, 15 August 2026.
Early detection of colorectal cancer via population‐based screening programs can reduce incidence and mortality, but current screening approaches are limited. This systematic review evaluated the screening potential of blood‐based circulating tumor DNA assays in asymptomatic screening populations.
Caroline Ledertoug Kahn, Maria Wissing Rasmussen, Jakob Kleif, Inge Søkilde Pedersen, Christina Therkildsen   +4 more
wiley   +1 more source

Longitudinal methylated ctDNA increases predict immunotherapy progression across solid tumors. [PDF]

J Liq Biopsy
Anees M, Wagner PL, Omstead A, Grayhack E, Sherry C, McDaniel LD, Varga MG, Hosseiny SMH, Laframboise W, Nakayama J, Krivak T, Weksler B, Dadgar N, Qazi SU, Bahary N, Bartlett DL, Tsao DS, Zaidi AH.   +17 more
europepmc   +1 more source

Clinical and Radiometabolic Correlatives of ddPCR Liquid Biopsy for BRAF V600 Mutated Melanoma

International Journal of Cancer, Volume 159, Issue 4, Page 1068-1078, 15 August 2026.
Commercial circulating tumor DNA (ctDNA) liquid biopsy tests are increasingly used for disease monitoring and surveillance in melanoma. However, data regarding the possible correlations between ctDNA and baseline clinical and radiometabolic parameters such as metastatic locations, tumor volume, and tumor glycolysis in patients with BRAF‐mutated ...
Ronen Stoff, Gokce Belge Bilgin, Yalda Nikanpour, Geoffrey B. Johnson, Benjamin R. Kipp, David M. Zahrieh, Katherine B. Geiersbach, Matthew S. Block, Svetomir N. Markovic   +8 more
wiley   +1 more source

Narrative review: clinical application and challenges of circulating tumor DNA in treatment response evaluation and prognostic prediction for esophageal cancer. [PDF]

J Thorac Dis
Gu R, Liu T, Jin H, Wang X.
europepmc   +1 more source

Genetics of mCRPC tracked in ctDNA [PDF]

Nature Reviews Clinical Oncology, 2016
openaire   +1 more source

High Sensitivity ctDNA Analysis Using a Novel Panel and NOIR-SS Technology for Monitoring Advanced Urothelial Carcinoma. [PDF]

Cancer Med
Danno T, Nakamura S, Taguchi S, Fujii Y, Teshima T, Sato Y, Kawai T, Kobayashi Y, Nagaoka K, Ueda Y, Matoba R, Kakimi K, Kume H.   +12 more
europepmc   +1 more source

Circulating tumor DNA-guided response evaluation in patients with previously treated gastroesophageal adenocarcinoma. [PDF]

Gastric Cancer
Iden CR, Øgaard N, Mustafa SM, Elle IC, Yilmaz M, Nordsmark M, Henriksen T, Kruse T, Thomassen M, Pfeiffer P, Andersen CL, Bæksgaard L, Qvortrup C, Mau-Sørensen M.   +13 more
europepmc   +1 more source

ctDNA identified in patients with CUP [PDF]

Nature Reviews Clinical Oncology, 2017
openaire   +1 more source

Early ctDNA Dynamics Predict Response to Mosperafenib in BRAF V600-Mutant Metastatic Colorectal Cancer. [PDF]

Cancer Res Commun
Serrano-Serrano ML, Godfried Sie C, Bechter O, Pretelli G, Vieito M, Fontana E, Han CH, Castañón Álvarez E, Matos I, Pinato DJ, Moreno I, Eefsen RL, Plummer R, Dummer R, Prenen H, Sutton J, Cinato E, Schnetzler G, Keshelava N, Roller A.   +19 more
europepmc   +1 more source

Evolution of AR and Non-AR Alterations in ctDNA of Patients with Metastatic Prostate Cancer Treated in the Phase III Alliance A031201 Trial. [PDF]

Clin Cancer Res
Valentín López JC, Yu C, Knutson TP, Kobilka A, Lyman J, Guo S, Luo B, Munro SA, Li Y, Heer R, Gaughan L, Morris MJ, Beltran H, Ryan CJ, Antonarakis ES, Armstrong AJ, Halabi S, Dehm SM.   +17 more
europepmc   +1 more source